Moxetumomab pasudotox-tdfk Intravenous and Tetracycline Topical application
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Tetracycline Topical application and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: tetracycline topical
Brand name:
Synonyms: Tetracycline (Topical application)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Tetrahydrozoline (Nasal)
- Moxetumomab pasudotox-tdfk Intravenous-Tetrahydrozoline and zinc ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Tetrahydrozoline Hydrochloride
- Moxetumomab pasudotox-tdfk Intravenous-Tetrahydrozoline ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Tetrofosmin
- Moxetumomab pasudotox-tdfk Intravenous-Tetterine
- Tetracycline Topical application-Moxifloxacin
- Tetracycline Topical application-Moxifloxacin (Systemic)
- Tetracycline Topical application-Moxifloxacin Hydrochloride
- Tetracycline Topical application-Moxifloxacin Injection
- Tetracycline Topical application-Moxifloxacin Intravenous
- Tetracycline Topical application-Moxifloxacin Tablets